The most common mistake in switching from injectable to oral is assuming the milligram number carries across. It does not, and the reason is bioavailability rather than arithmetic.
Key Takeaways
- Injectable and oral doses are not interchangeable — oral bioavailability is a fraction of subcutaneous.
- The approved oral semaglutide product uses a completely different dose scale from the injectable.
- Compounded oral preparations have no published bioavailability data, so conversion is a prescriber judgment.
- A switch usually means a fresh titration, not a direct swap at an equivalent dose.
- Weekly-to-daily is a routine change as significant as the dose change itself.
Why the milligram numbers do not transfer
A subcutaneous injection delivers essentially all of the dose into your system. An oral dose has to survive the gut or cross the oral mucosa, and only a fraction arrives. The approved oral semaglutide product's dose range reflects this directly — its numbers are on a different scale from the injectable product's for the same molecule.
For compounded oral preparations there is no published bioavailability figure at all. That means any conversion is a clinical judgment made by your prescriber based on their experience with that specific preparation, not a calculation you can perform.
| Question | Injectable | Oral |
|---|---|---|
| Dose delivered | Essentially the full dose | A fraction, varying by formulation and route |
| Frequency | Usually weekly | Usually daily |
| Timing constraints | None relating to food | Fasting window or contact time depending on format |
| Storage | Refrigerated | Room temperature |
| Missed dose impact | One missed week | One missed day — smaller per-event impact |
| Dose scale | Its own scale | A different scale for the same molecule |
MadeMed — Oral Semaglutide
Sublingual- Sublingual format — dissolves under the tongue, no swallowing water required
- Quarterly billing available at a lower effective monthly rate
- Optional membership program discounts refills
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
What a switch actually involves
In practice, switching usually means a fresh titration on the oral product rather than starting at an "equivalent" dose. Your prescriber selects a starting point on the oral scale and escalates from there, watching response and tolerability as they would with any new start.
This can feel like losing ground, and it is worth understanding why it happens: without published equivalence data, starting conservatively and titrating up is the approach that avoids both underdosing and overshooting.
MadeMed — Oral Tirzepatide
Sublingual- Sublingual tirzepatide is still relatively rare — most oral compounding is semaglutide
- Quarterly billing available
- Dose tiers are priced separately; confirm your tier at checkout
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
The routine change is bigger than people expect
A weekly injection is one decision a week. A daily oral dose with a timing constraint is seven decisions a week, each of which can go wrong. Adherence research consistently shows that dosing frequency affects persistence.
The compensating advantage is that a missed daily dose matters far less than a missed weekly one. The overall exposure is smoother, and one imperfect morning is a much smaller event.
Telos Rx
Flat pricing by plan length- Pricing is flat across dose tiers once your plan length is set
- 12-month plan carries the lowest monthly rate
- Cancel anytime; FSA/HSA accepted
Telos prices by commitment length rather than by milligram, which changes how you should compare it against dose-tiered competitors.
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
Questions to ask before switching
- What starting dose are you putting me on, and how does that relate to where I am now?
- Should I expect a period of reduced effect during the transition?
- What is the escalation schedule, and how quickly?
- What are the exact timing instructions for this specific preparation?
- If this does not work as well, what does going back look like?
The last question is the one people forget to ask and most often want the answer to.
Frequently Asked Questions
Can I switch from injectable to oral at the same dose?
No. Oral bioavailability is a fraction of subcutaneous, and the dose scales are different. A switch is a prescribing decision, not a substitution.
Will I lose progress during a switch?
A fresh titration means a period at lower exposure. Whether that translates into weight change depends on the individual and the length of the transition.
Is daily dosing harder to stick to?
More frequent dosing generally correlates with lower adherence, though a missed daily dose has a much smaller effect than a missed weekly one.
Can I switch back?
Generally yes, as another prescribing decision with its own titration. Ask before you switch so you know what the return path looks like.